Kazimierz Madalinski
Overview
Explore the profile of Kazimierz Madalinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grabarczyk P, Kubicka-Russel D, Kopacz A, Liszewski G, Sulkowska E, Zwolinska P, et al.
J Med Virol
. 2019 Nov;
92(3):339-347.
PMID: 31670401
Nucleic acid testing (NAT) was implemented in Poland in 1999 for screening of plasma for fractionation and for all blood donors in 2002. To analyze seronegative NAT-positive samples representing hepatitis...
2.
Rosinska M, Parda N, Kolakowska A, Godzik P, Zakrzewska K, Madalinski K, et al.
PLoS One
. 2017 Sep;
12(9):e0185055.
PMID: 28931062
Background & Aims: There is a considerable burden of hepatitis C in Europe related to the lack of prompt diagnosis. We aimed to estimate the prevalence and related risk factors...
3.
Parda N, Stepien M, Zakrzewska K, Madalinski K, Kolakowska A, Godzik P, et al.
BMJ Open
. 2016 Dec;
6(12):e013359.
PMID: 27927665
Objectives: Response rate in public health programmes may be a limiting factor. It is important to first consider their delivery and acceptability for the target. This study aimed at determining...
4.
5.
Sakem B, Madalinski K, Nydegger U, Stepien M, Godzik P, Kolakowska A, et al.
Ann Agric Environ Med
. 2016 Sep;
23(3):425-31.
PMID: 27660862
Objective: The aim of the study was to review available data on HCV in Poland and Switzerland, in order to compare the two European countries with respect to epidemiological situation...
6.
Madalinski K, Zakrzewska K, Kolakowska A, Godzik P
Przegl Epidemiol
. 2015 Nov;
69(3):459-64, 581-4.
PMID: 26519840
Aim Of Study: is the estimation of prevalence of HCV infection in fourteen Central and Eastern European countries (CEEC). Material And Methods: This review describes the comparative data of persons...
7.
Madalinski K, Kolakowska A, Godzik P
Przegl Epidemiol
. 2015 Apr;
69(1):47-51, 147-50.
PMID: 25862447
This paper presents current views on the persistence of immunity following vaccination against hepatitis B. Very high effectiveness of hepatitis B vaccination has been reported in a number of studies...
8.
Kolakowska A, Godzik P, Madalinski K
Med Dosw Mikrobiol
. 2015 Mar;
66(3-4):215-22.
PMID: 25804075
The prevalence of anti-HCV antibodies in pregnant women ranges from 0.1% to 3.6% worldwide. In Poland, one work was published on the prevalence of HCV antibodies in pregnant women. Based...
9.
Kolakowska A, Godzik P, Madalinski K
Med Dosw Mikrobiol
. 2014 Apr;
65(4):275-83.
PMID: 24730216
Introduction: According to WHO reports, there are 130-170 million persons chronically infected with hepatitis C virus on a global scale. There is no effective vaccine against HCV, and the current...
10.
Godzik P, Kolakowska A, Madalinski K, Stepien M, Zielinski A, Goralewska A, et al.
Przegl Epidemiol
. 2013 Mar;
66(4):575-80.
PMID: 23484383
Unlabelled: According to WHO data, there are 130-170 million hepatitis C virus (HCV) infected persons world-wide. Data on the prevalence of HCV infection in Poland is still insufficient. Objective: The...